AtriCure (ATRC) Payables (2010 - 2026)

AtriCure (ATRC) has reported Payables for 17 consecutive years, with $35.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables rose 39.61% year-over-year to $35.8 million in Q2 2026; TTM through Jun 2026 was $35.8 million, a 39.61% increase from a year earlier, with the FY2025 full-year figure at $25.3 million, up 1.11% from the prior year.
• Payables was $35.8 million for Q2 2026 at AtriCure, up from $30.6 million in the prior quarter.
• Over five years, Payables peaked at $35.8 million in Q2 2026 and troughed at $19.9 million in Q4 2022.
• A 5-year average of $26.0 million and a median of $25.2 million in 2025 frame the typical range for Payables.
• Across the five-year window, Payables surged 43.8% in 2022 and slipped 19.74% in 2025, its largest moves.
• Over 5 years, Payables stood at $19.9 million in 2022, then soared by 37.47% to $27.4 million in 2023, then fell by 8.49% to $25.0 million in 2024, then advanced by 1.11% to $25.3 million in 2025, then soared by 41.64% to $35.8 million in 2026.
• The last three Payables figures came in at $35.8 million (Q2 2026), $30.6 million (Q1 2026), and $25.3 million (Q4 2025), per Business Quant data.